Show simple item record

dc.contributor.authorDu, Simo
dc.contributor.authorCarfang, Laura
dc.contributor.authorRestrepo, Emily
dc.contributor.authorBenjamin, Christine
dc.contributor.authorEpstein, Mara M
dc.contributor.authorFairley, Ricki
dc.contributor.authorRoudebush, Laura
dc.contributor.authorHertz, Crystal
dc.contributor.authorEshraghi, Leah
dc.contributor.authorWarner, Erica T
dc.date.accessioned2022-10-26T14:57:54Z
dc.date.available2022-10-26T14:57:54Z
dc.date.issued2022-08-20
dc.identifier.citationDu S, Carfang L, Restrepo E, Benjamin C, Epstein MM, Fairley R, Roudebush L, Hertz C, Eshraghi L, Warner ET. Patient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19. Curr Oncol. 2022 Aug 20;29(8):5919-5932. doi: 10.3390/curroncol29080467. PMID: 36005205; PMCID: PMC9406797.en_US
dc.identifier.eissn1718-7729
dc.identifier.doi10.3390/curroncol29080467en_US
dc.identifier.pmid36005205
dc.identifier.urihttp://hdl.handle.net/20.500.14038/51215
dc.description.abstractOf 554 eligible survey participants, 493 provided complete data on demographic and socioeconomic factors and were included in the analysis. Approximately half (n = 248, 50.3%) had a personal history of breast cancer. Overall, 188 (38.1%) participants had experienced any COVID-19-related delay in care including screening, diagnosis, or treatment, and 339 (68.8) reported having at least one virtual appointment during the study period. Compared to other insurance types, participants with Medicaid insurance were 2.58 times more likely to report a COVID-19-related delay in care (OR 2.58, 95% Cl: 1.05, 6.32; p = 0.039). Compared to participants with a household income of less than USD 50,000, those with a household income of USD 150,000 or more were 2.38 (OR 2.38, 95% Cl: 1.09, 5.17; p = 0.029) times more likely to adopt virtual appointments. Self-insured participants were 70% less likely to use virtual appointment compared to those in other insurance categories (OR 0.28, 95% Cl: 0.11, 0.73; p = 0.009).en_US
dc.language.isoenen_US
dc.relation.ispartofCurrent Oncologyen_US
dc.relation.urlhttps://doi.org/10.3390/curroncol29080467en_US
dc.rightsCopyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).en_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19en_US
dc.subjectbreast canceren_US
dc.subjecthealth disparitiesen_US
dc.subjectmammographyen_US
dc.titlePatient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19en_US
dc.typeJournal Articleen_US
dc.source.journaltitleCurrent oncology (Toronto, Ont.)
dc.source.volume29
dc.source.issue8
dc.source.beginpage5919
dc.source.endpage5932
dc.source.countrySwitzerland
dc.identifier.journalCurrent oncology (Toronto, Ont.)
refterms.dateFOA2022-10-26T14:57:55Z
dc.contributor.departmentMedicineen_US
dc.contributor.departmentMeyers Health Care Instituteen_US


Files in this item

Thumbnail
Name:
curroncol-29-00467.pdf
Size:
676.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Except where otherwise noted, this item's license is described as Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).